Mica Duran

Tivantinib®: MET receptor and HGF ligand 

Prev Next
Previous

ACZ885-IL1B: Receptors

medical illustration of PowerPoint images and design for pharmaceutical method-of-action of Tivantinib, designed to block the activity of a molecule known as c-Met that plays multiple key roles in human cancer.
Next medical illustration of Color, Education, Medical Malpractice, Patient Education, Publishing, Medical-Legal, Personal Injury, Anatomy, General Medicine, Maternal / Child, Obstetrics / Gynecology, Reproductive Biology, Legal Exhibits

Pelvic Anatomy

PowerPoint images and design for pharmaceutical method-of-action of Tivantinib, designed to block the activity of a molecule known as c-Met that plays multiple key roles in human cancer.

Keywords: Airbrush, Color, Design, Information Graphics, Education, Allergy / Immunology, Biology, Biotechnology, Cell biology / Histology, Disease Management, Endocrinology / Metabolic, Molecular Biology, Pharmacology

© Mica Duran